ORGANOGENESIS HOLDINGS INC. Undistributed Earnings, Basic
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Undistributed Earnings, Basic of $25.66 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes
us-gaap:UndistributedEarnings · last filed 2026-02-26
- ORGANOGENESIS HOLDINGS INC. undistributed earnings, basic for the quarter ending 2025-12-31 was $40.76M, a 593.82% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. undistributed earnings, basic for the quarter ending 2025-09-30 was $18.69M, a 51.59% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. undistributed earnings, basic for the quarter ending 2024-12-31 was $5.88M.
- ORGANOGENESIS HOLDINGS INC. undistributed earnings, basic for the quarter ending 2024-09-30 was $12.33M.
- ORGANOGENESIS HOLDINGS INC. undistributed earnings, basic for fiscal 2025 was $25.66M.
- ORGANOGENESIS HOLDINGS INC. undistributed earnings, basic for fiscal 2024 was -$937.00K, a 118.95% decline from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. undistributed earnings, basic for fiscal 2023 was $4.95M.
| Period end | Undistributed Earnings, Basic 3 month | Undistributed Earnings, Basic 6 month | Undistributed Earnings, Basic 9 month | Undistributed Earnings, Basic 12 month |
|---|---|---|---|---|
| 2025-12-31 | $40.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $59.45M derived: sum of 2 quarters · filed 2026-02-26 | $25.66M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $18.69M 10-Q · filed 2025-11-06 | -$15.10M 10-Q · filed 2025-11-06 | ||
| 2024-12-31 | $5.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $18.21M derived: sum of 2 quarters · filed 2026-02-26 | -$937.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $12.33M 10-Q · filed 2025-11-06 | -$6.81M 10-Q · filed 2025-11-06 | ||
| 2023-12-31 | $4.95M 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |